UroGen Pharma Ltd. (URGN) Alert: Investors reminded of Class Action Lawsuit

Investors have been reminded by Levi and Korsinsky of the deadline for the URGN class action lawsuit, set for July 28, 2025. It is crucial for investors involved in this case to take note of this deadline to ensure that they do not miss out on potential compensation.

This class action lawsuit has been initiated due to alleged violations by URGN. The company is accused of making misleading statements and failing to disclose crucial information to investors. As a result, shareholders may have suffered financial losses due to these actions.

Investors who purchased URGN securities between December 20, 2021, and March 29, 2025, are eligible to join the class action lawsuit. It is important for affected investors to participate in this legal process to seek justice and potential recovery of their losses.

In order to be part of the lawsuit, investors must meet certain criteria and file their claims by the July 28, 2025 deadline. Failure to do so may result in being unable to participate in the lawsuit and potentially missing out on any compensation that may be awarded.

Levi and Korsinsky are actively working on behalf of investors to pursue justice in this case. Their expertise in handling class action lawsuits makes them a reliable source for investors seeking legal representation in matters related to securities fraud.

By joining the class action lawsuit, investors have the opportunity to hold URGN accountable for any alleged misconduct and seek recourse for any financial harm they have suffered. It is important for investors to take action and make their voices heard in seeking justice and potential compensation in this case.

Overall, the deadline for the URGN class action lawsuit is fast approaching, and investors must act quickly to ensure they do not miss out on the chance for potential recovery of their losses. Levi and Korsinsky are available to assist investors in navigating the legal process and seeking justice in this matter. With their expertise and dedication to protecting investors’ rights, affected individuals can trust in their ability to represent them effectively in the pursuit of justice.